Clinical trial Recruiting at 1 site Interventional Ages 18 and up

DIPB vs SIFIB for pain control after total hip replacement

Official title: Comparison of the Effects of Deep Iliacus Plane Block (DIPB) and Suprainguinal Fascia Iliaca Block (SIFIB) on Postoperative Analgesia in Patients Undergoing Hip Surgery: A Randomized Controlled Study

Run by Sivas Numune Hospital · NCT07452120 · Data updated 2026-11-12

This will test whether the Deep Iliacus Plane Block (DIPB) or the Suprainguinal Fascia Iliaca Block (SIFIB) gives better pain relief and less leg weakness for adults having elective total hip replacement.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment70 (estimated)
SponsorSivas Numune Hospital
Government
Locations2 sites (Sivas, Sivas and 1 other locations)
StatusRecruiting
StartedMarch 27, 2026
Main results expectedOctober 1, 2026
Study endsNovember 1, 2026
Registry record updatedApril 2, 2026
Trial IDNCT07452120 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (age ≥18) with ASA physical status I–III scheduled for elective primary total hip arthroplasty under spinal anesthesia who can provide informed consent are ideal candidates.

Probably not a fit

Patients with contraindications to regional anesthesia (such as coagulopathy, local infection), significant pre-existing lower limb neurological deficits, or inability to consent would not be eligible and are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this randomized, double-blind trial, 70 adults undergoing elective primary total hip arthroplasty under spinal anesthesia will be assigned to receive either a DIPB or a SIFIB at the end of surgery. Investigators will record postoperative pain scores, opioid consumption, motor block, and block-related complications over 48 hours. The primary aim is to determine whether DIPB provides superior or comparable analgesia with reduced motor blockade compared with SIFIB. Findings will help guide choice of regional analgesia to support earlier mobilization and safer recovery after hip replacement.

Why it matters

Potential benefit: If successful, the results could provide better pain control with less motor weakness, helping patients mobilize sooner after hip replacement.

How similar studies have gone: SIFIB is widely used and effective for cutaneous analgesia after hip surgery, while DIPB is a newer technique with anatomical and preliminary clinical reports suggesting improved deep joint analgesia but limited randomized evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged ≥18 years
* ASA physical status I-III
* Scheduled for elective primary total hip arthroplasty under spinal anesthesia
* Ability to understand the study procedures and provide informed consent

Exclusion Criteria:

* Coagulation disorders or anticoagulant therapy contraindicating regional anesthesia
* Infection at the block application site
* Hemodynamic instability
* Known allergy to local anesthetics
* Pre-existing significant neurological or motor deficits in the lower extremities
* Cognitive impairment preventing pain assessment
* Refusal to participate or inability to provide informed consent

Where it's running

  • Sivas Numune Hospital
    Sivas, Turkey (Türkiye)
    Recruiting
  • Sivas Numune Hospital
    Sivas, Sivas, Turkey (Türkiye)
    Not yet recruiting

Study contacts

  • Principal investigator: Fatih BALCI — Sivas Numune Hospital, Department of Anesthesiology and Reanimation
  • Study coordinator: Fatih Balcı, MD
  • Email: fatihbalci05@gmail.com
  • Phone: +90 545 864 76 57

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.